An interventional study of Predictability and language context in Healthy, sponsored by University of California, San Diego. Recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-12.
Sponsored by University of California, San Diego · Not applicable, Interventional, and Basic science
This study aims to investigate how unimodal bilinguals who speak two languages and bimodal bilinguals who speak one language and sign another control languages across comprehension and production. Participants will complete different language tasks (e.g., classify a word, name a picture) in different languages, and their behavioral performance will be assessed, including accuracy and reaction time.
University of California, San Diego is the lead sponsor of 958 studies on the registry; 191 are open to participants now.
Of its 110 completed or terminated interventional studies of FDA-regulated products, 70 (64%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Behavioral: Predictability · Behavioral: language context
Behavioral: Predictability · Behavioral: language context
Behavioral: Predictability · Behavioral: language context
Whether the task of the next trial (comprehension or production) is predictable
whether both languages or only one language is involved in the current block
Switch costs in different contexts
Time frame: An average of one year for each condition
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, San Diego